Showing results (411-420 of 752) with videos related to
Sort By:
Pageof 76
Frontiers in Neuroscience|April 24, 2024
In vitro characterization of [125I]HY-3-24, a selective ligand for the dopamine D3 receptorJi Youn Lee, Ho Young Kim, Paul Martorano, et al.Biochemistry|March 5, 2003
Inhibition of nuclear import mediated by the Rev-arginine rich motif by RNA moleculesKonstantin Fineberg, Tali Fineberg, Adolf Graessmann, et al.The Journal of Pain|February 8, 2005
Physical and emotional functioning of adult patients with chronic abdominal pain: comparison with patients with chronic back painCynthia O Townsend, Christopher D Sletten, Barbara K Bruce, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|October 16, 2004
Value of the clinical history for different users of dermoscopy compared with results of digital image analysisA Blum, R Hofmann-Wellenhof, H Luedtke, et al.The Clinical Journal of Pain|January 23, 2009
Impact of tobacco use in patients presenting to a multidisciplinary outpatient treatment program for fibromyalgiaToby N Weingarten, Vikram R Podduturu, W Michael Hooten, et al.Medchemcomm|October 25, 2013
Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligandsZhude Tu, Shihong Li, Aixiao Li, et al.Sensors (Basel, Switzerland)|February 28, 2023
Explainable Artificial Intelligence (XAI) in Pain Research: Understanding the Role of Electrodermal Activity for Automated Pain RecognitionPhilip Gouverneur, Frédéric Li, Kimiaki Shirahama, et al.Frontiers in Public Health|October 31, 2022
Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year onHalinder S Mangat, Anwar Musah, Susanne Luedtke, et al.Cell Host & Microbe|October 22, 2013
Tracking viral genomes in host cells at single-molecule resolutionI-Hsuan Wang, Maarit Suomalainen, Vardan Andriasyan, et al.Pharmacology, Biochemistry, and Behavior|October 12, 2018
Dopamine D3 receptor partial agonist LS-3-134 attenuates cocaine-motivated behaviorsGregory L Powell, John Paul Bonadonna, Annika Vannan, et al.Pageof 76